$189,61
-$3,38(-1,75 %)
*Data last updated: 2026-04-11 08:33 (UTC+8)
As of 2026-04-11 08:33, Danaher (DHR) is priced at $189,61, with a total market cap of $134,08B, a P/E ratio of 44,80, and a dividend yield of 0,71 %. Today, the stock price fluctuated between $189,44 and $193,49. The current price is 0,08 % above the day's low and 2,00 % below the day's high, with a trading volume of 3,18M. Over the past 52 weeks, DHR has traded between $180,03 to $242,80, and the current price is -21,90 % away from the 52-week high.
DHR Key Stats
Yesterday's Close$192,99
Market Cap$134,08B
Volume3,18M
P/E Ratio44,80
Dividend Yield (TTM)0,71 %
Dividend Amount$0,40
Diluted EPS (TTM)5,10
Net Income (FY)$3,61B
Revenue (FY)$24,56B
Earnings Date2026-04-21
EPS Estimate1,94
Revenue Estimate$5,99B
Shares Outstanding694,75M
Beta (1Y)0.986
Ex-Dividend Date2026-03-27
Dividend Payment Date2026-04-24
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
SectorHealthcare
IndustryMedical - Diagnostics & Research
CEORainer Blair
HeadquartersWashington,DC,US
Official Websitehttps://www.danaher.com
Employees (FY)60,00K
Average Revenue (1Y)$409,46K
Net Income per Employee$60,23K
Erfahren Sie mehr über Danaher (DHR)
Danaher (DHR) FAQ
What's the stock price of Danaher (DHR) today?
x
Danaher (DHR) is currently trading at $189,61, with a 24h change of -1,75 %. The 52-week trading range is $180,03–$242,80.
What are the 52-week high and low prices for Danaher (DHR)?
x
What is the price-to-earnings (P/E) ratio of Danaher (DHR)? What does it indicate?
x
What is the market cap of Danaher (DHR)?
x
What is the most recent quarterly earnings per share (EPS) for Danaher (DHR)?
x
Should you buy or sell Danaher (DHR) now?
x
What factors can affect the stock price of Danaher (DHR)?
x
How to buy Danaher (DHR) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.
